Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · IRIDEX CORP (IRIX)

IRIDEX receives Nasdaq notice over $1.00 minimum bid price; cure period to Feb. 23, 2027

Negative Impact 4 of 5 legal/regulatory Written later

IRIDEX received a Nasdaq notice on August 27, 2026 saying its stock had closed below the $1.00 minimum bid price for 30 consecutive business days. The company has until February 23, 2027 to regain compliance, and the filing says the notice has no immediate effect on the stock's listing or trading.

Key points

  • Nasdaq notice received August 27, 2026 for the $1.00 minimum bid price requirement on the Nasdaq Capital Market
  • Cure period runs 180 calendar days to February 23, 2027; compliance requires a closing bid of at least $1.00 for 10 consecutive business days
  • If not cured, the company may qualify for a second 180-day period, which may require a reverse stock split; otherwise delisting proceedings and an appeal right would follow

The filing

CompanyIRIDEX CORP (IRIX)
Form8-K, current report
Filed with the SECSep 2, 2026, 4:20 PM ET
Accession number0001193125-26-380229

Items reported: 3.01 Delisting / Listing Rule Notice

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 02, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.